Ranibizumab Approved in EU for Myopia ComplicationRanibizumab Approved in EU for Myopia Complication
A clinical trial has shown that patients with choroidal neovascularization generally experienced better vision after 1 injection of the vascular endothelial growth factor inhibitor. International Approvals
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Ophthalmology News Alert Source Type: news
More News: Clinical Trials | Health | Lucentis | Myopia (short sighted) | Opthalmology | Ranibizumab Injection